Nav1.5 Ser571 Phosphorylation in Cardiac Aging

Aging is associated with delayed ventricular repolarization, impaired diastolic filling, and declining myocardial reserve, but the molecular events connecting these phenotypes have remained incompletely defined. The research article Phosphorylation of cardiac sodium channel at Ser571 anticipates manifestations of the aging myopathy, published in the American Journal of Physiology–Heart and Circulatory Physiology in 2024, addresses this problem by focusing on the late sodium current, or INa,L, carried by Nav1.5.

Rather than treating increased late sodium current as a passive consequence of aging, the investigators tested whether phosphorylation of Nav1.5 at Ser571 actively drives electrical and mechanical deterioration. The results position INa,L as a mechanistic link between prolonged repolarization and defective myocardial relaxation, while also illustrating how genetic gain- and loss-of-function models can strengthen interpretation of pharmacological inhibition studies.

Study Background and Research Question

Cardiac sodium channels normally open briefly during the action potential and then inactivate. A small persistent current remains when a fraction of channels fails to inactivate completely. Under pathological conditions, this late current can increase sodium entry during the action potential plateau, promote secondary calcium loading through sodium–calcium exchange, and prolong electrical recovery. These processes are relevant to heart failure, ischemic stress, oxidative injury, and inherited sodium-channel disorders.

The authors build on earlier observations that aging increases INa,L in ventricular myocytes. In the experimental context summarized by the study, late sodium current was approximately 60% higher in myocytes from old mice than in cells from young adult animals, while action-potential duration measured at 90% repolarization was approximately 50% longer. These age comparisons involved mice about 26–30 months old versus animals around 3 months of age, as reported in the reference study.

The central question was whether Nav1.5 phosphorylation at Ser571 is causally involved in this remodeling. Specifically, the study asked whether increasing or stabilizing INa,L through targeted Nav1.5 mutations would shift the timing and severity of age-associated abnormalities in electrocardiographic repolarization, left ventricular filling, calcium handling, and myocyte contraction–relaxation.

Key Innovation from the Reference Study

The major innovation is the use of genetically engineered mice to separate the effect of Ser571 signaling from the many structural, metabolic, and inflammatory changes that accompany normal aging. Phosphomimetic gain-of-function animals were used to model enhanced late sodium current, whereas phosphoablated loss-of-function animals provided a contrasting model in which the current was stabilized or prevented from undergoing the same age-related increase.

This design creates a temporal test of mechanism. If increased INa,L is merely correlated with aging, modifying Nav1.5 phosphorylation should have limited influence on when cardiac dysfunction appears. Instead, the study found that gain of function made repolarization and relaxation defects appear earlier, while loss of function attenuated several abnormalities in old animals. That pattern supports a causal contribution from the Nav1.5 phosphorylation state.

The work is also important because it connects electrical and mechanical phenotypes rather than examining them separately. Prolonged repolarization and impaired diastolic filling were studied alongside calcium-transient decay and the kinetics of cell shortening and relengthening. This integrated view suggests that late sodium current is not only an arrhythmia-related signal but also a determinant of how efficiently aged myocardium relaxes between contractions.

Methods and Experimental Design Insights

The investigators compared wild-type C57BL/6 mice with Nav1.5 Ser571 gain-of-function and loss-of-function lines. Wild-type males and females were included, and the study used age-stratified cohorts to distinguish adult, aging, and old phenotypes. In the reported experiments, adult animals were approximately 5 months old, the aging cohort was approximately 18 months old, and old myocytes were approximately 24 months old; the study details these comparisons in the published report.

At the whole-animal level, electrocardiographic measurements were used to evaluate ventricular repolarization, including QT-interval behavior. Cardiac assessment also examined left ventricular diastolic filling. At the cell level, isolated ventricular myocytes were evaluated for calcium-transient kinetics and mechanical shortening, including the speed of contraction and relengthening. The combination of in vivo cardiac measurements and ex vivo cellular analysis is a useful in vitro cardiac electrophysiology framework because it links organ-level timing defects with cell-level ion-handling and mechanical changes.

Pharmacological inhibition of INa,L was used as a functional rescue experiment in the aging wild-type setting. This is an important methodological distinction: inhibition was not the sole basis for assigning causality, because the genetic models independently altered the relevant channel regulatory state. For researchers planning ventricular myocyte sodium current inhibition experiments, the study therefore supports a workflow that uses genetic controls, electrophysiological readouts, and mechanical or calcium-based endpoints together.

Protocol Parameters

• Age-stratified comparison: Separate adult, aging, and old cohorts to determine whether a phenotype is accelerated, delayed, or intensified by the Nav1.5 Ser571 genotype; the reference study used cohorts centered at approximately 5, 18, and 24 months.
• Genetic perturbation: Compare wild-type animals with phosphomimetic gain-of-function and phosphoablated loss-of-function Nav1.5 Ser571 models rather than relying on a single pharmacological condition.
• Electrical endpoint: Pair electrocardiographic QT assessment with cellular action-potential or late-current measurements so that prolonged repolarization can be related to the underlying sodium-channel phenotype.
• Relaxation endpoint: Measure calcium-transient decay and myocyte relengthening alongside shortening amplitude or kinetics; delayed recovery in both domains provides stronger evidence for diastolic remodeling than either measurement alone.
• Rescue experiment: Apply INa,L inhibition as a mechanistic test in age-related dysfunction, while interpreting the result alongside untreated genotype-matched controls and avoiding the assumption that acute rescue reproduces long-term aging biology.

Core Findings and Why They Matter

Wild-type mice in the aging cohort developed prolonged QT intervals and impaired left ventricular diastolic filling. Importantly, both defects were reversed when late sodium current was inhibited, according to the reference study. This finding links an electrophysiological abnormality to a clinically meaningful aspect of cardiac performance and indicates that increased INa,L is functionally relevant rather than an incidental feature of aged myocardium.

The gain-of-function model shifted the phenotype to an earlier stage. Adult gain-of-function mice already displayed prolonged repolarization and impaired ventricular filling, and their cellular calcium and contractile abnormalities became more severe with further aging. In contrast, loss-of-function animals showed substantially attenuated repolarization changes in old age and comparatively limited deterioration in myocyte mechanics. The genotype-dependent timing is one of the strongest arguments that Ser571 regulation participates in disease progression.

At the myocyte level, aged wild-type cells exhibited slower calcium-transient decay and delayed shortening and relengthening kinetics compared with adult cells. Similar abnormalities were present prematurely in gain-of-function cells, whereas loss-of-function cells were relatively protected. These results support a mechanistic sequence in which excess late sodium entry alters intracellular sodium and calcium handling, prolongs action-potential recovery, and slows relaxation.

The implications extend beyond a single aging phenotype. Prolonged repolarization can increase electrical instability, while delayed calcium clearance can compromise diastolic function and reduce the ability of the ventricle to accommodate filling. The study therefore informs arrhythmia prevention research and diastolic dysfunction research simultaneously, although it does not by itself establish efficacy against a defined clinical arrhythmia.

Comparison with Existing Internal Articles

The internal article Nav1.5 Ser571 Phosphorylation, Late INa, and Cardiac Aging Myopathy emphasizes the same regulatory axis and frames Ser571 phosphorylation as a precision target for cardiac aging research. Its value is conceptual synthesis. The reference study supplies the primary experimental foundation for that interpretation by combining engineered mouse models with organ-level and cellular measurements.

This distinction matters for literature-focused workflows. A mechanistic overview can suggest why late sodium current deserves attention, but the 2024 study shows how to test the hypothesis experimentally: manipulate the channel regulatory site, examine age-dependent timing, and determine whether the electrical phenotype tracks with calcium and mechanical recovery. The paper consequently provides a stronger basis for designing ventricular myocyte sodium current inhibition experiments than a discussion based on current measurements alone.

Limitations and Transferability

The study has several boundaries. First, it is an animal study using engineered mouse Nav1.5 alleles. Mouse repolarization, calcium handling, heart rate, and age-related remodeling do not reproduce every feature of human myocardium. The findings establish biological plausibility and mechanism in vivo, but they do not substitute for studies in human ventricular myocytes, human tissue, or clinical cohorts.

Second, a constitutive phosphomimetic or phosphoablated allele may affect channel regulation throughout development and adulthood. Such models are powerful for causal inference, but they may not fully mimic the timing, reversibility, or cell-specific distribution of phosphorylation changes acquired during human aging. Conditional or temporally controlled approaches could help distinguish developmental effects from late-life remodeling.

Third, acute late-current inhibition demonstrates reversibility of selected phenotypes but does not determine whether long-term suppression prevents heart failure progression or improves survival. The work also focuses on aging-related dysfunction rather than directly testing ischemia-induced arrhythmia studies. Results should therefore not be generalized automatically to ischemia, drug-induced torsades de pointes, or other arrhythmic settings without dedicated validation.

Finally, the relationship between delayed repolarization and impaired relaxation is strongly supported by the coordinated measurements, but additional work is needed to resolve how channel phosphorylation interacts with accessory proteins, oxidative signaling, ventricular loading, and regional myocardial heterogeneity. These limitations define useful next steps rather than weakening the central conclusion that Nav1.5 Ser571 regulation is a meaningful determinant of late sodium current behavior in the aging heart.

Research Support Resources

For pharmacological follow-up of this mechanism, researchers can use GS967 (SKU B5850), a cardiac late sodium current inhibitor, to support comparable ventricular myocyte and cardiac electrophysiology workflows. APExBIO describes it as a selective research compound for late INa studies; it should be used alongside appropriate genetic controls and is intended for scientific research only, not for diagnostic or medical use.